Herbalife price target raised to $17 from $16 at B. Riley

B. Riley analyst Jeff Van Sinderen raised the firm’s price target on Herbalife to $17 from $16 and keeps a Buy rating on the shares following the “mixed” Q2 report. While noting increased currency headwinds, pricing was the primary revenue driver, more than offsetting a 6% volume decline, the analyst tells investors in a research note. The firm says recent trends and guidance indicate that ongoing headwinds reduce the probability of achieving year-over-year metric improvement for fiscal 2024.